| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ATHEROSCLEROSIS.2006.05.031 |
| P698 | PubMed publication ID | 16837000 |
| P50 | author | Elisa Anamaria Liehn | Q30347994 |
| Christian Weber | Q37838769 | ||
| P2093 | author name string | Peter Hanrath | |
| Rüdiger Blindt | |||
| Mihail Hristov | |||
| Nicole Heussen | |||
| Carolin Becker | |||
| Christian Fach | |||
| P433 | issue | 2 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 413-420 | |
| P577 | publication date | 2006-07-11 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment | |
| P478 | volume | 192 |
| Q41944621 | Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources |
| Q63915163 | An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood |
| Q37231424 | Assessing identity, phenotype, and fate of endothelial progenitor cells |
| Q37152177 | Atherosclerosis as a disease of failed endogenous repair |
| Q92510057 | Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity In Vitro but Not In Vivo |
| Q33681013 | CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage |
| Q41813965 | Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity. |
| Q36628329 | Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors |
| Q38419242 | Circulating endothelial progenitor cells: Do they live up to their name? |
| Q33989134 | Circulating progenitor cells and scleroderma |
| Q33751575 | Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria |
| Q42918754 | Clozapine Mobilizes CD34+ Hematopoietic Stem and Progenitor Cells and Increases Plasma Concentration of Interleukin 6 in Patients With Schizophrenia |
| Q42016510 | Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction |
| Q39806709 | DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells |
| Q35712258 | Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients. |
| Q28082426 | Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on? |
| Q48302634 | Effect of intensive multifactorial treatment on vascular progenitor cells in hypertensive patients. |
| Q42849047 | Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients |
| Q82469776 | Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial |
| Q45916411 | Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. |
| Q36566280 | Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial |
| Q80534318 | Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence |
| Q37290687 | Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside |
| Q39332638 | Endothelial Progenitor Cells for the Vascularization of Engineered Tissues |
| Q37098713 | Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. |
| Q37403696 | Endothelial progenitor cells in acute ischemic stroke. |
| Q34038864 | Endothelial progenitor cells in cardiovascular diseases |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q39121106 | Endothelial progenitor cells: Exploring the pleiotropic effects of statins |
| Q21198698 | Endothelial progenitor cells: what use for the cardiologist? |
| Q57146961 | Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study |
| Q84733019 | Insulin resistance and oxidative stress influence colony-forming unit-endothelial cells capacity in obese patients |
| Q33258314 | Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis |
| Q42874906 | Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies |
| Q36562557 | Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds |
| Q31153048 | Mobilization of CD133+ progenitor cells in patients with acute cerebral infarction |
| Q33808599 | Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries |
| Q53189136 | Predictors of circulating endothelial progenitor cell levels in patients without known coronary artery disease referred for multidetector computed tomography coronary angiography. |
| Q37053167 | Progenitor cells and vascular disease |
| Q36887613 | Residential Proximity to Major Roadways Is Associated With Increased Levels of AC133+ Circulating Angiogenic Cells. |
| Q38078140 | Restoring stem cell mobilization to promote vascular repair in diabetes. |
| Q63285817 | Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients |
| Q86695109 | Statin use and peripheral blood progenitor cells mobilization in patients with multiple myeloma |
| Q34475689 | Targeting stem cell niches and trafficking for cardiovascular therapy |
| Q35076387 | Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? |
| Q36342262 | The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy. |
| Q37325951 | The effect of aspirin on endothelial progenitor cell biology: preliminary investigation of novel properties |
| Q37282249 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models |
Search more.